Navigation Links
NeurogesX Reports Second Quarter 2009 Results
Date:8/7/2009

common stockholders 17,580,158 17,516,667 17,574,455 17,492,531 ========== ========== ========== ========== Non-cash stock-based compensation expense included in operating expenses: (1) Research and development $189 $215 $448 $413 (2) General and administrative 201 180 449 381 --- --- --- --- $390 $395 $897 $794 ==== ==== ==== ==== NEUROGESX, INC. (A Development Stage Company) CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) June 30, December 31, 2009 2008 ------- ------------ (unaudited) (1) ----------- --- Assets Current assets: Cash and cash equivalents $4,914 $10,435 Short-term investments 8,524 14,071 Receivable from collaboration partner 48,787 -- Prepaid expenses and other current assets 471 412 Restricted cash 40 40 -- -- Total current assets 62,736 24,958 Property and equipment, net 380 468 Restricted cash 160 160
'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
2. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
3. NeurogesX Added to Russell 3000 Index
4. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
5. NeurogesX to Present at Needham Life Sciences Conference
6. NeurogesX Receives European Commission Approval for Qutenza(TM)
7. NeurogesX Reports First Quarter 2009 Results
8. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
9. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
10. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
11. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... ROCKVILLE, Md., Nov. 20 ...at it has priced an underwritten public offering o...to the public of $3.30 per share. The approximate...e underwriting discounts and commissions, will be ...f our VLP-based vaccines, internal research and de...
(Date:11/20/2009)... METTLER TOLEDO recently announced th...ss Optimization Using At-Line Particle Characteriz...9. In this webinar, the application of in situ pa... design space and optimize a series of roller comp...s, and roller compaction forces. , ...
(Date:11/19/2009)...PENHAGEN, Nov. 19 Danish Prince Jo...ulosic ethanol plant in Kalundborg, Denmark, on We...orld,s first and largest 2nd generation ethanol de...enzymes are used in the plant,s innovative process...n of Danisco, was the first to market with commerc...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-Firs...n innovator in biotechnology for diabetes therapy,...ting services to food, supplement, biotechnology a...osed the previously reported $6.3 million register...2,760,870 shares of its common stock and warrants ...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
... Service Industries debuts PAKS...ne for medical pouches & sachets from Ireland-... Belfast, Ireland (PRWEB) March 16, 2009 -- A l... pouches and sachets which is manufactured by Nort...debut through U.S. distributor Service Industries ...
...IEGO, March 16 Prometheus Laboratories Inc., a sp...ounced today that it has received New York State a...t and only blood test for irritable bowel syndrome...s, two of which are proprietary, along with a prop...ents with IBS. , , "One out of five Americans has...
...LE, March 16 /PRNewswire-FirstCall/ - Oncothyreon ... company specializing in the development of innova...cer, today announced that on March 12, 2009, it re...t Oncothyreon had re-gained full compliance with t...l Market. , The notice followed a review of Oncoth...
Other Biology Technology:U.S. Distributor Debut for PAKSCAN - a Pouch & Sachet Leak Tester Machine from Ireland-based Sepha Ltd. 2U.S. Distributor Debut for PAKSCAN - a Pouch & Sachet Leak Tester Machine from Ireland-based Sepha Ltd. 3Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome 2Oncothyreon regains compliance with NASDAQ listing requirements 2
(Date:11/19/2009)...ov. 19 BIO-key Internati... wireless public safety and finger-based biometric...ial Shareholder Meeting held today was adjourned w... not present. ,, (Logo: http://www.newscom.com...impressive 99.3% of the 35 million votes cast vote...
(Date:11/19/2009)...due University scientists have helped identify and...l wall development in maize, an effort that expand...omass best suited for biofuels production. , The...fessor of plant cell biology, published their find...ant Physiology on Thursday (Nov. 19). They also w...
(Date:11/19/2009)...s Competitive NIH Director,s T-R01 Award , Speedi..., Dr. Samie Jaffrey, associate professor of phar...g the first researchers to win a prestigious NIH D...al Institutes of Health. Dr. Jaffrey and his colle...n technologies that may some day speed up lab test...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Maize cell wall genes identified, giving boost to biofuel research 2Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Glaucoma Tied to Gene Variants in Blacks 57942 1Glaucoma Tied to Gene Variants in Blacks 57942 2Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 1Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 2Cohera Medical Receives ISO 13485 Certification 3A Company Meets International Standards for Design Development and Manufacturing of Medical Devices 57932 1Cohera Medical Receives ISO 13485 Certification 3A Company Meets International Standards for Design Development and Manufacturing of Medical Devices 57932 2
...ven false established medical practice that an ant...liver infections was safe to use on its own in pat...trate that treatment with entecavir leads to cross... the AIDS virus. , "Our results show that entecavi...wn to be active against HIV - it breeds resistance...
...ealth care and medicine, but current technologies ...keup. Any patient wanting a complete picture of th... at the sight of the bill -- to the current tune o...ammalian-sized genome sequenced. , Now, with a gra...nstitute (NHGRI), scientists at the Biodesign Inst...
...sonous bites they use for defense. But what can no...t if they could borrow a dose of poison by eating ...s exactly what happens in the relationship between...o a team of researchers funded by the National Sci...nismal Systems (IOS). , Herpetologists Deborah ...
Other Biology News:Widely used hepatitis B drug spurs HIV drug resistance 2Widely used hepatitis B drug spurs HIV drug resistance 3Faster, low cost sequencing technologies needed to drive era of personalized medicine 2Faster, low cost sequencing technologies needed to drive era of personalized medicine 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2
Solvent-Detergent Removal Resin from Sigma-Aldrich
...station automates a wide array of research and dia...ample Preparation to Bio-Molecular and Cell Based ...er Sciclone enables numerous combinations of pipet... needs of a given application, and should the unit...
Nunc OmniTray from Sigma-Aldrich
...m Caliper represents a revolutionary breakthrough ...rst time the ability to generate real-time perform...onditions. In addition, each channel automaticall...ges in temperature, and offers its own liquid leve...
Biology Products: